Cardlytics Q2 Adj EPS $(0.24) Beats $(0.43) Estimate, Sales $76.70M Beat $69.54M Estimate
Portfolio Pulse from vinayak@benzinga.com
Cardlytics reported Q2 adjusted EPS of $(0.24), beating the estimate of $(0.43) by 44.19%. The company also reported quarterly sales of $76.70M, surpassing the estimate of $69.54M by 10.30%. Both figures represent an increase from the same period last year.
August 04, 2023 | 10:24 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardlytics' Q2 results exceeded estimates, which could positively impact the stock in the short term.
Cardlytics reported better-than-expected Q2 results, beating both EPS and sales estimates. This positive financial performance could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100